Zhitong Finance App News, Fu'an Pharmaceutical (300194.SZ) issued an announcement. Fuan Pharmaceutical Group Chongqing Bosheng Pharmaceutical Co., Ltd. (hereinafter referred to as “Bosheng Pharmaceutical”), a wholly-owned subsidiary of the company, recently received a notice of approval for the marketing application of chemical raw materials issued by the State Drug Administration. The active ingredient is “cefazolin sodium”. Once approved for marketing, the above API products can be used in domestically marketed formulations, which will further enrich the subsidiary's product line.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.